リツキシマブ医薬品市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00019327
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

市場紹介

リツキシマブは、特定の自己免疫疾患やがんの種類の治療に使用される薬で、リツキサンという商品名で販売されています。非ホジキンリンパ腫、慢性リンパ性白血病、関節リウマチ、特発性血小板減少性紫斑病、多発血管炎を伴う肉芽腫症、尋常性天疱瘡、重症筋無力症、エプスタイン・バーウイルス陽性皮膚粘膜潰瘍などに使用されます。静脈へのゆっくりとした注射によって投与されます。

市場のダイナミクス

慢性疾患(がん、関節炎、糖尿病など)の発生率の増加や研究と医薬品開発の増加などの要因により、リツキシマブ医薬品市場の需要が刺激されます。さらに、強力な臨床試験/製品パイプラインと新しい医薬品市場プレーヤーの参入により、予測期間中に市場の成長が大幅に促進されるでしょう。ただし、薬の副作用は、予測期間内の市場の成長を妨げます。

市場範囲

「2028 年までの世界リツキシマブ医薬品市場分析」は、世界市場動向分析に特に焦点を当てた専門的で詳細な調査です。このレポートは、種類、投与経路、用途、地域ごとに詳細な市場分割を行い、リツキシマブ医薬品市場の概要を提供することを目的としています。世界のリツキシマブ医薬品市場は、予測期間中に高い成長を遂げると予想されています。このレポートは、リツキシマブ医薬品市場の主要プレーヤーの市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション

世界のリツキシマブ医薬品市場は、種類、投与経路、および適用によって分割されています。世界のリツキシマブ医薬品市場は、タイプに基づいて 100 mg と 500 mg に分類されます。世界のリツキシマブ医薬品市場は、投与経路に基づいて静脈内投与と皮下投与に分類されます。世界のリツキシマブ医薬品市場は、用途に応じて血液がん、自己免疫疾患、臓器移植に分類されます。

地域的枠組み

このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界のリツキシマブ医薬品市場の概要と予測を提供します。また、北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米の 5 つの主要地域に関して、2019 年から 2028 年までの市場規模と予測推定値も提供します。各地域別のリツキシマブ医薬品市場は、後にそれぞれの国およびセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要と供給の両方の側面からリツキシマブ医薬品市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートはまた、北米、欧州、APAC、MEA、中南米の5つの地域すべてについて、これらの地域のリツキシマブ医薬品市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、徹底的なPEST分析を提供しています。

市場関係者

このレポートでは、有機的および無機的な成長戦略としてリツキシマブ医薬品市場の主要な動向を取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。リツキシマブ医薬品市場の市場関係者は、世界市場でのリツキシマブ医薬品市場の需要の高まりに伴い、将来的に有利な成長機会が得られると予想されています。以下に挙げるのは、リツキシマブ医薬品市場に従事する数社のリストです。レポートには、SWOT分析と市場戦略とともに、主要なリツキシマブ医薬品市場企業のプロフィールも含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。
    •  F. ホフマン・ラ・ロッシュ株式会社 • 中外製薬株式会社 • 日本全薬工業株式会社 •  AryoGen Pharmed •  Intas Pharmaceuticals Ltd. • ヘテロ • エムキュア・ファーマシューティカルズ •  Nexus Lifecare Private Limited • リライアンス ライフ サイエンス •  Actlife Sciences Private Limited
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成され、既存の調査にさまざまなカスタマイズ オプションを提供します。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. F. Hoffmann-La Roche Ltd
2. Chugai Pharmaceutical Co., Ltd.
3. Nippon Zenyaku Kogyo Co., Ltd.
4. AryoGen Pharmed
5. Intas Pharmaceuticals Ltd.
6. Hetero
7. Emcure Pharmaceuticals
8. Nexus Lifecare Private Limited
9. Reliance Life Sciences
10. Actlife Sciences Private Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports